A lifestyle program for treated hypertensives improved health-related behaviors and cardiovascular risk factors, a randomized controlled trial

被引:52
作者
Burke, Valerie [1 ]
Beilin, Lawrie J.
Cutt, Hayley E.
Mansour, Jacqueline
Williams, Amy
Mori, Trevor A.
机构
[1] Univ Western Australia, Royal Perth Hosp Unit, Sch Med & Pharmacol, Cardiovasc Res Ctr, Perth, WA 6847, Australia
[2] Western Australian Inst Med Res, Perth, WA, Australia
基金
英国医学研究理事会;
关键词
hypertension; lifestyle modification; lipids; glucose; insulin; weight;
D O I
10.1016/j.jclinepi.2006.05.012
中图分类号
R19 [保健组织与事业(卫生事业管理)];
学科分类号
摘要
Objective: To assess effects of a cognitively based program on health-related behaviors and cardiovascular risk factors in overweight drug-treated hypertensives. Study Design and Setting: In a clinical trials center, volunteers, recruited by advertisement, were randomized to usual care (N = 118) or to a 4-month program (N = 123) incorporating weight loss; a low-sodium diet, high in fruit, vegetables, and fish; and increased physical activity. Diet, physical activity, weight, blood lipids, glucose, and insulin were measured at 4 and 16 months. Results: Ninety-eight usual care and 106 program participants completed the 4-month assessment; 90 and 102, respectively, completed follow-up. Using intention-to-treat analysis, relative to usual care, net changes with the program at 4 months were as follows: dietary fat (-2.6% energy; P < 0.001); sodium (-290 mg/d; P = 0.004); energy (-313 mJ/d; P = 0.005); fish (+2.1 serves/wk; P < 0.001); vegetables (+3.0 serves/wk; P < 0.001); physical activity (+37 min/wk; P = 0.004); weight (-2.8 kg; P < 0.001); waist girth (-3.1 cm; P < 0.001); total cholesterol (-0.2 mmol/L; P = 0.017); and triacylglycerol s (-0.12 mmol/L; P = 0.002). One year later, net changes included dietary fat (-2.2% energy; P < 0.001); sodium (- 150 mg/d; P = 0.029); fish (+2.0 serves/wk; P < 0.001); vegetables (+4.3 serves/wk; P < 0.001); weight (-2.5 kg; P = 0.001); waist girth (-3.1 cm; P < 0.001); high-density lipoprotein cholesterol (+0.03 mmol/L; P = 0.031). Conclusion: Improvements in behaviors and risk factors, several maintained long term, suggest the potential for long-term benefits in hypertensives. (c) 2007 Elsevier Inc. All rights reserved.
引用
收藏
页码:133 / 141
页数:9
相关论文
共 30 条
[1]  
Appel Lawrence J., 1995, Annals of Epidemiology, V5, P119, DOI 10.1016/1047-2797(94)00056-Y
[2]  
Appel LJ, 2003, JAMA-J AM MED ASSOC, V289, P2083, DOI 10.1001/jama.289.16.2083
[3]   A clinical trial of the effects of dietary patterns on blood pressure [J].
Appel, LJ ;
Moore, TJ ;
Obarzanek, E ;
Vollmer, WM ;
Svetkey, LP ;
Sacks, FM ;
Bray, GA ;
Vogt, TM ;
Cutler, JA ;
Windhauser, MM ;
Lin, PH ;
Karanja, N .
NEW ENGLAND JOURNAL OF MEDICINE, 1997, 336 (16) :1117-1124
[4]   Effects of a lifestyle programme on ambulatory blood pressure and drug dosage in treated hypertensive patients: a randomized controlled trial [J].
Burke, V ;
Beilin, LJ ;
Cutt, HE ;
Mansour, J ;
Wilson, A ;
Mori, TA .
JOURNAL OF HYPERTENSION, 2005, 23 (06) :1241-1249
[5]   Physical activity and nutrition programs for couples: A randomized controlled trial [J].
Burke, V ;
Giangiulio, N ;
Gillam, HF ;
Beilin, LJ ;
Houghton, S .
JOURNAL OF CLINICAL EPIDEMIOLOGY, 2003, 56 (05) :421-432
[6]  
BURKE V, IN PRESS HLTH ED RES
[7]  
CHLEBOWSKI RT, 1994, CANCER, V74, P2734, DOI 10.1002/1097-0142(19941101)74:9+<2734::AID-CNCR2820741824>3.0.CO
[8]  
2-U
[9]   Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure [J].
Chobanian, AV ;
Bakris, GL ;
Black, HR ;
Cushman, WC ;
Green, LA ;
Izzo, JL ;
Jones, DW ;
Materson, BJ ;
Oparil, S ;
Wright, JT ;
Roccella, EJ .
HYPERTENSION, 2003, 42 (06) :1206-1252
[10]   Executive summary of the Third Report of the National Cholesterol Education Program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel III) [J].
Cleeman, JI ;
Grundy, SM ;
Becker, D ;
Clark, LT ;
Cooper, RS ;
Denke, MA ;
Howard, WJ ;
Hunninghake, DB ;
Illingworth, DR ;
Luepker, RV ;
McBride, P ;
McKenney, JM ;
Pasternak, RC ;
Stone, NJ ;
Van Horn, L ;
Brewer, HB ;
Ernst, ND ;
Gordon, D ;
Levy, D ;
Rifkind, B ;
Rossouw, JE ;
Savage, P ;
Haffner, SM ;
Orloff, DG ;
Proschan, MA ;
Schwartz, JS ;
Sempos, CT ;
Shero, ST ;
Murray, EZ .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2001, 285 (19) :2486-2497